Show simple item record

dc.contributor.authorVega, Francisco M.
dc.contributor.authorGautier, Violette
dc.contributor.authorFernández Ponce, Cecilia Matilde 
dc.contributor.authorExtremera, M.J.
dc.contributor.authorAltelaar, A.F.M.
dc.contributor.authorMillan, Jaime
dc.contributor.authorTellez, Juan C.
dc.contributor.authorHernandez-Campos, J.A.
dc.contributor.authorConejero, Rosario
dc.contributor.authorBolívar Pérez, Jorge 
dc.contributor.authorPardal, R.
dc.contributor.authorGarcía Cózar, Francisco José 
dc.contributor.authorAguado Vidal, Enrique 
dc.contributor.authorHeck, Albert J.R.
dc.contributor.authorDurán Ruiz, María del Carmen 
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2024-02-02T08:00:45Z
dc.date.available2024-02-02T08:00:45Z
dc.date.issued2017-02-20
dc.identifier.issn0022-2828
dc.identifier.urihttp://hdl.handle.net/10498/30489
dc.description.abstractEndothelial progenitor cells (EPCs) constitute a promising alternative in cardiovascular regenerative medicine due to their assigned role in angiogenesis and vascular repair. In response to injury, EPCs promote vascular remodeling by replacement of damaged endothelial cells and/or by secreting angiogenic factors over the damaged tissue. Nevertheless, such mechanisms need to be further characterized. In the current approach we have evaluated the initial response of early EPCs (eEPCs) from healthy individuals after direct contact with the factors released by carotid arteries complicated with atherosclerotic plaques (AP), in order to understand the mechanisms underlying the neovascularization and remodeling properties assigned to these cells. Herein, we found that the AP secretome stimulated eEPCs proliferation and mobilization ex vivo, and such increase was accompanied by augmented permeability, cell contraction and also an increase of cell-cell adhesion in association with raised vinculin levels. Furthermore, a comparative mass spectrometry analysis of control versus stimulated eEPCs revealed a differential expression of proteins in the AP treated cells, mostly involved in cell migration, proliferation and vascular remodeling. Some of these protein changeswere also detected in the eEPCs isolated from atherosclerotic patients compared to eEPCs from healthy donors. We have shown, for the first time, that the AP released factors activate eEPCs ex vivo by inducing their mobilization together with the expression of vasculogenic related markers. The present approach could be taken as a ex vivo model to study the initial activation of vascular cells in atherosclerosis and also to evaluate strategies looking to potentiate the mobilization of EPCs prior to clinical applications.es_ES
dc.description.sponsorshipInstituto Nacional de Salud Carlos III (PI12-02680 y PI16-00784); Prime XS-Consortium, EU Seventh Framework Programme (XS-000158) y European Research Council (ERC Starting Grant). Andalucía Talent Hub Program_Andalusian Knowledge Agency, co-funded by the EU Seventh Framework Programme (COFUND – Grant n° 291780).es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherELSEVIER SCI LTDes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceJournal of Molecular and Cellular Cardiology - Vol. 105, Pages 12 - 23es_ES
dc.subjectEndothelial progenitor cellses_ES
dc.subjectAtherosclerosises_ES
dc.subjectCell therapyes_ES
dc.subjectProteomicses_ES
dc.subjectCell migrationes_ES
dc.titleThe atheroma plaque secretome stimulates the mobilization of endothelial progenitor cells ex vivoes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsclosed accesses_ES
dc.identifier.doi10.1016/j.yjmcc.2017.02.001
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/291780/EU es_ES
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional